Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Observational Study of Patients Suffering From Endometriosis and Adenomyosis 04/27/2021 OBSERVATIONAL unchanged 1,947.85 0 Adaptation and Evaluation of a Tobacco Cessation Program: An Integrated mHealth Approach 04/29/2021 INTERVENTIONAL unchanged 1,945.85 0 Pembrolizumab and Lenvatinib in Advanced Cervical Cancer 04/29/2021 INTERVENTIONAL unchanged 1,945.85 0 Female Fertility, Environmental Agents and Stress Oxidant 04/29/2021 OBSERVATIONAL unchanged 1,945.85 0 Placenta Accreta Spectrum Outcome After Uterine Conservation 04/30/2021 INTERVENTIONAL unchanged 1,944.85 0 The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction 05/03/2021 OBSERVATIONAL unchanged 1,941.85 0 Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy) 05/03/2021 INTERVENTIONAL unchanged 1,941.85 0 Post-Marketing Study of Prucalopride Safety In Pregnancy 05/03/2021 OBSERVATIONAL unchanged 1,941.85 0 The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories 05/04/2021 INTERVENTIONAL unchanged 1,940.85 0 Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET 05/04/2021 INTERVENTIONAL unchanged 1,940.85 0 Treatment to Regress to Normoglycemia in Women with a Recent History of GDM 05/05/2021 INTERVENTIONAL unchanged 1,939.85 0 Breast Cancer Index (BCI) Registry 05/06/2021 OBSERVATIONAL unchanged 1,938.85 0 Prospective Evaluation of Topical Almond Oil vs Hydroquinone 05/06/2021 INTERVENTIONAL unchanged 1,938.85 0 A Study of Intra-operative Imaging in Women With Ovarian Cancer 05/07/2021 INTERVENTIONAL unchanged 1,937.85 0 Junctional Zone and Its Relation to Outcomes in Assisted Reproductive Technology 05/07/2021 OBSERVATIONAL unchanged 1,937.85 0 Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa 05/07/2021 INTERVENTIONAL unchanged 1,937.85 0 Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy 05/07/2021 OBSERVATIONAL unchanged 1,937.85 0 REDUCE Trial- Reducing Prolapse Recurrence 05/10/2021 INTERVENTIONAL unchanged 1,934.85 0 Sex or no Sex: That is the Question. 05/11/2021 OBSERVATIONAL unchanged 1,933.85 0 A Study of Attention and Memory Processes in Breast Cancer Survivors 05/12/2021 OBSERVATIONAL unchanged 1,932.85 0 D9319C00001- 1L OC Mono Global RCT 05/13/2021 INTERVENTIONAL unchanged 1,931.85 0 Vaginal NOTES Hysterectomy Versus Vaginal Hysterectomy 05/14/2021 INTERVENTIONAL unchanged 1,930.85 0 Indications for Breast Reduction in the Public Health Care System 05/17/2021 OBSERVATIONAL unchanged 1,927.85 0 Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers 05/18/2021 INTERVENTIONAL unchanged 1,926.85 0 A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery 05/18/2021 INTERVENTIONAL unchanged 1,926.85 0 Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency 05/19/2021 INTERVENTIONAL unchanged 1,925.85 0 Circadian Rhythms in Postmenopausal Women 05/19/2021 INTERVENTIONAL unchanged 1,925.85 0 Novel Imaging Technique to Assess Gynecologic Cancer 05/19/2021 INTERVENTIONAL unchanged 1,925.85 0 Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer 05/20/2021 INTERVENTIONAL unchanged 1,924.85 0 A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus 05/24/2021 INTERVENTIONAL unchanged 1,920.85 0 Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence 05/24/2021 INTERVENTIONAL unchanged 1,920.85 0 Measles and BCG Vaccines for Mother and Child 05/24/2021 INTERVENTIONAL unchanged 1,920.85 0 Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age. 05/26/2021 OBSERVATIONAL unchanged 1,918.85 0 Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening 05/27/2021 INTERVENTIONAL unchanged 1,917.85 0 Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery 05/28/2021 INTERVENTIONAL unchanged 1,916.85 0 Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors 05/28/2021 INTERVENTIONAL unchanged 1,916.85 0 Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer 05/28/2021 INTERVENTIONAL unchanged 1,916.85 0 Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation 06/01/2021 INTERVENTIONAL unchanged 1,912.85 0 Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden 06/02/2021 INTERVENTIONAL unchanged 1,911.85 0 FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study 06/03/2021 OBSERVATIONAL unchanged 1,910.85 0 Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer 06/04/2021 INTERVENTIONAL unchanged 1,909.85 0 All-extremity Exercise During Breast Cancer Chemotherapy 06/04/2021 INTERVENTIONAL unchanged 1,909.85 0 The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing 06/08/2021 OBSERVATIONAL unchanged 1,905.85 0 Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique 06/08/2021 OBSERVATIONAL unchanged 1,905.85 0 Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer 06/08/2021 INTERVENTIONAL unchanged 1,905.85 0 The Clinical Features and Pregnancy Outcomes of CTD Patients 06/09/2021 OBSERVATIONAL unchanged 1,904.85 0 Mother-Infant Cohort Study in Malaysia and China 06/09/2021 OBSERVATIONAL unchanged 1,904.85 0 Intervention to Reduce Exposure to Environmental COntaminant (IRECO) 06/09/2021 INTERVENTIONAL unchanged 1,904.85 0 APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion 06/09/2021 INTERVENTIONAL unchanged 1,904.85 0 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer 06/10/2021 INTERVENTIONAL unchanged 1,903.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology